Unknown

Dataset Information

Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase.


ABSTRACT: Onconase is a ribonuclease that presents both antitumor and antiviral properties linked to its ribonucleolytic activity and represents a new class of RNA-damaging drugs. It has reached clinical trials for the treatment of several cancers and human papilloma virus warts. Onconase targets different RNAs in the cell cytosol but Onconase-treated cells present features that are different from a simple arrest of protein synthesis. We have used microarray-derived transcriptional profiling to identify Onconase-regulated genes in two ovarian cancer cell lines (NCI/ADR-RES and OVCAR-8). RT-qPCR analyses have confirmed the microarray findings. We have identified a network of up-regulated genes implicated in different signaling pathways that may explain the cytotoxic effects exerted by Onconase. Among

SUBMITTER: Vert A 

PROVIDER: S-EPMC5355296 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature